BVF Partners L P/il, Director Other at Kymera Therapeutics, Inc. (KYMR), bought 575,629 shares at $14.21 ($8.3M) on 2022-05-26, disclosed to the SEC on 2022-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.21 | 10,642 | $151K | 1.8% |
| 2 | $14.21 | 10,642 | $151K | 1.8% |
| 3 | $14.21 | 90,372 | $1.3M | 15.6% |
| 4 | $14.21 | 90,372 | $1.3M | 15.6% |
| 5 | $14.21 | 123,043 | $1.7M | 21.2% |
| 6 | $14.21 | 123,043 |
| $1.7M |
| 21.2% |
| 7 | $14.78 | 3,223 | $48K | 0.6% |
| 8 | $14.78 | 26,353 | $389K | 4.7% |
| 9 | $14.78 | 26,353 | $389K | 4.7% |
| 10 | $14.78 | 35,793 | $529K | 6.4% |
| 11 | $14.78 | 35,793 | $529K | 6.4% |
| Total | $14.34 avg | 575,629 | $8.3M | 100% |
| Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |
| XOMA | BUY | 2020-03-17 | $2.4M | — | Filing → |